{"transactions":[{"id":680959,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-08-19T22:35:15.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":2813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option share vest in 24 equal monthly installments commencing on August 1, 2026, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":2813,"derivative":{"exercise_price":11.245,"expiration_date":"2036-08-16","underlying":"Voting Common Stock","underlying_shares":2813},"source":{"system":"sec-edgar","filing":"0001709954-26-000012","document":"form4-08192026_060811.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000012/form4-08192026_060811.xml","form_type":"4"}},{"id":680958,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-08-19T22:35:15.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":24455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/4th of the total shares underlying the option shall vest on July 1, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":24455,"derivative":{"exercise_price":11.245,"expiration_date":"2036-08-16","underlying":"Voting Common Stock","underlying_shares":24455},"source":{"system":"sec-edgar","filing":"0001709954-26-000012","document":"form4-08192026_060811.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000012/form4-08192026_060811.xml","form_type":"4"}},{"id":680957,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Voting Common Stock","published_at":"2026-08-19T22:35:15.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":2222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents an RSU award. The RSUs shall vest in 8 equal quarterly installments commencing on October 1, 2026, subject to the Reporting Person's continued service through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of voting common stock of the Issuer."}],"balance_after":152482,"source":{"system":"sec-edgar","filing":"0001709954-26-000012","document":"form4-08192026_060811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000012/form4-08192026_060811.xml","form_type":"4"}},{"id":680956,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Voting Common Stock","published_at":"2026-08-19T22:35:15.000Z","date":"2026-08-17","kind":"grant","planned":false,"acquired":true,"shares":6020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. 1/4th of the RSUs shall vest on July 1, 2027, and 1/16th of the RSUs shall vest on each subsequent October 1, January 1, April 1 and July 1 thereafter, subject to the Reporting Person's continued service through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of voting common stock of the Issuer."}],"balance_after":150260,"source":{"system":"sec-edgar","filing":"0001709954-26-000012","document":"form4-08192026_060811.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000012/form4-08192026_060811.xml","form_type":"4"}},{"id":705576,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Voting Common Stock","published_at":"2026-07-20T10:00:17.000Z","date":"2026-07-17","kind":"sale","planned":true,"acquired":false,"shares":900,"price":38.17,"value":34353.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"shares","element":"transactionShares","label":"F6","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.37 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":144240,"source":{"system":"sec-edgar","filing":"0001709954-26-000010","document":"form4-07202026_060704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000010/form4-07202026_060704.xml","form_type":"4"}},{"id":705575,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Voting Common Stock","published_at":"2026-07-20T10:00:17.000Z","date":"2026-07-17","kind":"sale","planned":true,"acquired":false,"shares":16969,"price":37.61,"value":638204.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"shares","element":"transactionShares","label":"F6","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":145140,"source":{"system":"sec-edgar","filing":"0001709954-26-000010","document":"form4-07202026_060704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000010/form4-07202026_060704.xml","form_type":"4"}},{"id":705574,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Voting Common Stock","published_at":"2026-07-20T10:00:17.000Z","date":"2026-07-17","kind":"sale","planned":true,"acquired":false,"shares":600,"price":36.51,"value":21906.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"shares","element":"transactionShares","label":"F6","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.91 to $36.89 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":162109,"source":{"system":"sec-edgar","filing":"0001709954-26-000010","document":"form4-07202026_060704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000010/form4-07202026_060704.xml","form_type":"4"}},{"id":705573,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Voting Common Stock","published_at":"2026-07-20T10:00:17.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":1476,"price":37.44,"value":55261.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.26 to $37.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":162709,"source":{"system":"sec-edgar","filing":"0001709954-26-000010","document":"form4-07202026_060704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000010/form4-07202026_060704.xml","form_type":"4"}},{"id":705572,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Voting Common Stock","published_at":"2026-07-20T10:00:17.000Z","date":"2026-07-16","kind":"sale","planned":true,"acquired":false,"shares":6979,"price":36.66,"value":255850.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.12 to $37.11 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":164185,"source":{"system":"sec-edgar","filing":"0001709954-26-000010","document":"form4-07202026_060704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000010/form4-07202026_060704.xml","form_type":"4"}},{"id":705571,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Voting Common Stock","published_at":"2026-07-20T10:00:17.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":4699,"price":36.94,"value":173581.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.68 to $37.325 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":171164,"source":{"system":"sec-edgar","filing":"0001709954-26-000010","document":"form4-07202026_060704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000010/form4-07202026_060704.xml","form_type":"4"}},{"id":705570,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAO and Interim CFO"}}],"security":"Voting Common Stock","published_at":"2026-07-20T10:00:17.000Z","date":"2026-07-15","kind":"sale","planned":true,"acquired":false,"shares":5356,"price":36.13,"value":193512.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of minimum statutory tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary sale by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.68 to $36.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":175863,"source":{"system":"sec-edgar","filing":"0001709954-26-000010","document":"form4-07202026_060704.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000010/form4-07202026_060704.xml","form_type":"4"}},{"id":797800,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Voting Common Stock","published_at":"2026-04-29T20:30:35.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":700,"price":30.83,"value":21581.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.81 to $30.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":181219,"source":{"system":"sec-edgar","filing":"0001709954-26-000008","document":"form4-04292026_040431.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000008/form4-04292026_040431.xml","form_type":"4"}},{"id":797799,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Voting Common Stock","published_at":"2026-04-29T20:30:35.000Z","date":"2026-04-28","kind":"sale","planned":true,"acquired":false,"shares":17235,"price":30.33,"value":522737.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.755 to $30.71 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":181919,"source":{"system":"sec-edgar","filing":"0001709954-26-000008","document":"form4-04292026_040431.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000008/form4-04292026_040431.xml","form_type":"4"}},{"id":797798,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Voting Common Stock","published_at":"2026-04-29T20:30:35.000Z","date":"2026-04-27","kind":"sale","planned":true,"acquired":false,"shares":14363,"price":30.46,"value":437496.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.27 to $30.64 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":199154,"source":{"system":"sec-edgar","filing":"0001709954-26-000008","document":"form4-04292026_040431.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000008/form4-04292026_040431.xml","form_type":"4"}},{"id":797797,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Voting Common Stock","published_at":"2026-04-29T20:30:35.000Z","date":"2026-04-27","kind":"sale","planned":true,"acquired":false,"shares":29623,"price":29.6,"value":876840.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.27 to $30.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":213517,"source":{"system":"sec-edgar","filing":"0001709954-26-000008","document":"form4-04292026_040431.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000008/form4-04292026_040431.xml","form_type":"4"}},{"id":797796,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Voting Common Stock","published_at":"2026-04-29T20:30:35.000Z","date":"2026-04-27","kind":"sale","planned":true,"acquired":false,"shares":7914,"price":28.94,"value":229031.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.27 to $29.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":243140,"source":{"system":"sec-edgar","filing":"0001709954-26-000008","document":"form4-04292026_040431.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000008/form4-04292026_040431.xml","form_type":"4"}},{"id":805112,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Voting Common Stock","published_at":"2026-04-17T20:05:20.000Z","date":"2026-04-15","kind":"sale","planned":false,"acquired":false,"shares":3590,"price":26.61,"value":95529.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold to cover the statutory tax withholding obligations in connection with the vesting of the restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.6045 to $26.6093 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 121 shares acquired under the Issuer's stock purchase plan on March 31, 2026."}],"balance_after":251054,"source":{"system":"sec-edgar","filing":"0001709954-26-000006","document":"form4-04172026_040413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000006/form4-04172026_040413.xml","form_type":"4"}},{"id":913946,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-02-09T22:50:15.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":24455,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the total shares underlying the option shall vest on February 5, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":24455,"derivative":{"exercise_price":15.7,"expiration_date":"2036-02-04","underlying":"Voting Common Stock","underlying_shares":24455},"source":{"system":"sec-edgar","filing":"0001709954-26-000004","document":"form4-02092026_050212.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000004/form4-02092026_050212.xml","form_type":"4"}},{"id":913945,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Voting Common Stock","published_at":"2026-02-09T22:50:15.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":6020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. 1/4th of the RSUs shall vest on January 1, 2027, and 1/16th of the RSUs shall vest on each subsequent April 1, July 1, October 1 and January 1 thereafter, subject to the Reporting Person's continued service through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of voting common stock of the Issuer."}],"balance_after":254523,"source":{"system":"sec-edgar","filing":"0001709954-26-000004","document":"form4-02092026_050212.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000004/form4-02092026_050212.xml","form_type":"4"}},{"id":927670,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Voting Common Stock","published_at":"2026-01-29T21:30:10.000Z","date":"2026-01-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":22050,"price":17.98,"value":396459.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of restricted stock unit awards. The securities of the Issuer retained by the Reporting Person remain subject to the terms a lock-up agreement entered into with the underwriters for the Issuer's initial public offering, pursuant to which the Reporting Person agreed, subject to certain exceptions, not to directly or indirectly sell or otherwise transfer securities of the Issuer for a period of 180 days following the date of the final prospectus relating to the initial public offering, which was October 26, 2025."}],"balance_after":248503,"source":{"system":"sec-edgar","filing":"0001709954-26-000002","document":"form4-01292026_040103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995426000002/form4-01292026_040103.xml","form_type":"4"}},{"id":1012426,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-10-28T20:15:18.000Z","date":"2025-10-27","kind":"grant","planned":false,"acquired":true,"shares":124022,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/4th of the total shares underlying the option shall vest on October 1, 2026, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":124022,"derivative":{"exercise_price":17,"expiration_date":"2035-10-26","underlying":"Voting Common Stock","underlying_shares":124022},"source":{"system":"sec-edgar","filing":"0001709954-25-000007","document":"form4-10282025_041014.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995425000007/form4-10282025_041014.xml","form_type":"4"}},{"id":1012425,"issuer":{"id":5316,"kind":"organization","name":"MapLight Therapeutics, Inc.","symbol":"MPLT"},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CAAO and PAO"}}],"security":"Voting Common Stock","published_at":"2025-10-28T20:15:18.000Z","date":"2025-10-27","kind":"grant","planned":false,"acquired":true,"shares":30565,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. 1/4th of the RSUs shall vest on October 1, 2026, and 1/16th of the RSUs shall vest on each subsequent January 1, April 1, July 1 and October 1 thereafter, subject to the Reporting Person's continued service through each vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of voting common stock of the Issuer."}],"balance_after":30565,"source":{"system":"sec-edgar","filing":"0001709954-25-000007","document":"form4-10282025_041014.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1709954/000170995425000007/form4-10282025_041014.xml","form_type":"4"}},{"id":3735104,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-12-12T00:39:37.000Z","date":"2018-05-10","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Reporting Person has the right to exercise these options for a three-year period after any termination of his employment (other than for cause)."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the reverse stock split of Millendo common stock, effective as of December 7, 2018."}],"balance_after":5000,"derivative":{"exercise_price":13.98,"expiration_date":"2028-05-10","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-062113","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1544227/000120919118062113/doc4.xml","form_type":"4"}},{"id":4068193,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Senior Vice President, Finance"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-09T23:23:44.000Z","date":"2018-02-08","kind":"grant","acquired":true,"shares":128645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 25% of the shares on February 8, 2019 and the remaining shares shall vest in equal quarterly installments over 12 quarters, ending February 8, 2022."}],"balance_after":128645,"derivative":{"exercise_price":0.93,"expiration_date":"2028-02-08","underlying":"Common Stock","underlying_shares":128645},"source":{"system":"sec-edgar","filing":"0001179110-18-001912","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1544227/000117911018001912/edgar.xml","form_type":"4"}},{"id":4273216,"issuer":{"id":7734,"kind":"organization","name":"Tempest Therapeutics, Inc."},"owners":[{"id":21505,"kind":"person","name":"GILLIS JONATHAN","position":1,"cik":"0001709954","reported_name":"GILLIS JONATHAN","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President Finance"}}],"security":"Stock Option (right to buy)","published_at":"2017-06-24T00:54:19.000Z","date":"2017-06-21","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest as to 25% of the shares on June 14, 2018 and the remaining shares shall vest in equal quarterly installments over 12 quarters, ending on June 14, 2021."}],"balance_after":30000,"derivative":{"exercise_price":1.46,"expiration_date":"2017-06-21","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001179110-17-009550","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1544227/000117911017009550/edgar.xml","form_type":"4"}}]}